- Published on
Toxicology – Carisoprodol Toxicity
Source
Carisoprodol is a centrally acting skeletal muscle relaxant, often prescribed alone or in combination with other agents such as aspirin or codeine. It has a relatively rapid onset (about 30 minutes) and a short duration of action. The drug is metabolized into meprobamate, an active compound with sedative properties.
Typical Presentation
Patients may present with overdose or misuse, often in combination with other substances such as opioids or alcohol. Requests for specific medications and recurrent visits may raise suspicion for misuse.
Clinical Features
Toxicity produces features of a sedative-hypnotic syndrome. Symptoms include central nervous system depression, drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, hypotension, and bradycardia. Severe cases may progress to coma, seizures, respiratory depression, or arrest. Some patients may paradoxically exhibit increased muscle tone, hyperreflexia, or abnormal posturing.
Mechanism of Action
Carisoprodol and its metabolite meprobamate enhance activity at GABA(A) receptors, producing sedative effects similar to barbiturates. Abrupt discontinuation after chronic use can lead to withdrawal symptoms resembling those seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with attention to airway protection, breathing, and circulation. Monitoring is essential, especially in cases of suspected coingestion with other central nervous system depressants.
Key Points
Source
Carisoprodol is a centrally acting skeletal muscle relaxant, often prescribed alone or in combination with other agents such as aspirin or codeine. It has a relatively rapid onset (about 30 minutes) and a short duration of action. The drug is metabolized into meprobamate, an active compound with sedative properties.
Typical Presentation
Patients may present with overdose or misuse, often in combination with other substances such as opioids or alcohol. Requests for specific medications and recurrent visits may raise suspicion for misuse.
Clinical Features
Toxicity produces features of a sedative-hypnotic syndrome. Symptoms include central nervous system depression, drowsiness, poor coordination, ataxia, slurred speech, nausea, vomiting, hypotension, and bradycardia. Severe cases may progress to coma, seizures, respiratory depression, or arrest. Some patients may paradoxically exhibit increased muscle tone, hyperreflexia, or abnormal posturing.
Mechanism of Action
Carisoprodol and its metabolite meprobamate enhance activity at GABA(A) receptors, producing sedative effects similar to barbiturates. Abrupt discontinuation after chronic use can lead to withdrawal symptoms resembling those seen with alcohol or benzodiazepines.
Management
Treatment is supportive, with attention to airway protection, breathing, and circulation. Monitoring is essential, especially in cases of suspected coingestion with other central nervous system depressants.
Key Points
- Frequently abused due to its sedative and euphoric effects.
- Often taken in combination with opioids or alcohol, increasing risk of severe toxicity.
- Withdrawal can occur with abrupt cessation after prolonged use.
0 Comments
